Macomber Lori

Track

Insider profile

Performance

Overall performance
0.5
Performance over holding periods
0.5
30 days 90 days 120 days
Average return -40% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Macomber Lori's trades of Karyopharm Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-04 2026-02-03
S Sale
50,830 +0.1%
150.23
US$3,547,165 		50,830 +0.1% 150.23 US$3,547,165
2025-03-13 2025-03-13
PrS Proposed sale
4,000
74.95
US$4,987,471 		4,000 74.95 US$4,987,471
2025-01-10 2025-01-10
PrS Proposed sale
76,987
226.66
US$3,129,279 		76,987 226.66 US$3,129,279
2024-12-26 2024-12-24
PrS Proposed sale
189
32.45
US$6,134 		189 32.45 US$6,134
2024-09-20 2024-09-20
PrS Proposed sale
90,060
48.91
US$4,405,003 		90,060 48.91 US$4,405,003
2024-06-25 2024-06-25
PrS Proposed sale
1,492
42.66
US$63,642 		1,492 42.66 US$63,642
2024-03-25 2024-03-25
PrS Proposed sale
905
56.95
US$51,540 		905 56.95 US$51,540
2023-12-22 2023-12-22
PrS Proposed sale
681
57.80
US$39,364 		681 57.80 US$39,364
2023-09-22 2023-09-22
PrS Proposed sale
119
63.20
US$7,521 		119 63.20 US$7,521
2023-06-22 2023-06-22
PrS Proposed sale
700
74.32
US$52,026 		700 74.32 US$52,026
2023-04-21 2023-04-21
PrS Proposed sale
2,167
70.00
US$151,690 		2,167 70.00 US$151,690
2023-04-19 2023-04-19
PrS Proposed sale
3,533
60.00
US$211,980 		3,533 60.00 US$211,980
2023-04-05 2023-04-05
PrS Proposed sale
853
46.53
US$39,687 		853 46.53 US$39,687